• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Shimadzu Corporation Announces Partnership to Sell Touchless Image-Control Solution

Article

A one-year renewable agreement will let Shimadzu Medical Systems USA market the TIPSO AirPad, potentially safeguaring sterilization in interventional radiology procedures.

Diagnostic medical imaging systems company Shimadzu Corporation announced Monday that its subsidiary Shimadzu Medical Systems USA signed a one-year renewable agreement with Canadian company NZ Technologies to market the TIPSO AirPad® in the U.S. market.

TIPSO technology is largely used in interventional radiology procedures, and, according to a company press release, the AirPad will let providers move images during a procedure without actually touching them. Limiting contact will safeguard sterility as operators won’t need to scrub in and out in order to consult images.

AirPad is a palm-sized, portable, wireless solution that offers multimodal imaging control that uses finger taps and twirls to manage image orientation and adjustments, according to the press release. It sits as a mouse and keyboard at the bedside while a representation of a hand and a menu pops up on the system monitor display. 

The AirPad connects to any workstation via a USB dongle without interfacing with the hospital networking or any type of transfer or storage of patient data, helping to maintain HIPAA compliance. By providing ready-access to live and historical images, the technology could reduce the need for additional scans, as well as decrease operative time, the company said.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.